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Abstract
G-quadruplexes (G4s) are four-stranded DNA secondary structures, which are involved in a diverse range of biological
processes. Although the anti-cancer potential of G4s in oncogene promoters has been thoroughly investigated, the
functions of promoter G4s in non-cancer-related genes are not well understood. We have explored the possible regulatory
roles of promoter G4s in cardiac function-related genes using both computational and a wide range of experimental
approaches. According to our bioinformatics results, it was found that potential G4-forming sequences are particularly
enriched in the transcription regulatory regions (TRRs) of cardiac function-related genes. Subsequently, the promoter of
human cardiac troponin I (TnIc) was chosen as a model, and G4s found in this region were subjected to biophysical
characterisations. The chromosome 19 specific minisatellite G4 sequence (MNSG4) and near transcription start site (TSS) G4
sequence (280 G4) adopt anti-parallel and parallel structures respectively in 100 mM KCl, with stabilities comparable to
those of oncogene G4s. It was also found that TnIc G4s act cooperatively as enhancers in gene expression regulation in
HEK293 cells, when stabilised by a synthetic G4-binding ligand. This study provides the first evidence of the biological
significance of promoter G4s in cardiac function-related genes. The feasibility of using a single ligand to target multiple G4s
in a particular gene has also been discussed.
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Introduction
Although the majority of human genomic DNA adopts the
iconic double helical structure (also known as B-form or duplex
DNA) proposed by Watson and Crick [1], other non-B-form DNA
secondary structures formed within certain sequences in the
human genome have also been revealed in many in vivo and in vitro
studies, such as the G-quadruplex DNA (G4 DNA) and i-motifs (i-
tetraplexes) formed in oligonucleotides with guanine and cytosine
tracts respectively (reviewed in [2,3]). As 98% of the human
genome is non-coding, the possible biological functions of these
transient and dynamic non-B-form DNA structures have been a
subject of increasing interest.
As compared to other non-B-form DNA, G4s are relatively
stable in solution under near-physiological conditions (thermody-
namic and kinetic stability of G4s are reviewed in [4] and [5],
respectively), which enables them to compete with adjacent duplex
DNA and therefore participate in certain biological processes. The
accumulated distribution of G4s in gene promoter regions
throughout the human genome also makes them particularly
important as compared to other non-B-form DNA structures [6].
Unsurprisingly, there have been a growing number of studies on
the biological functions of these DNA structures, since the
discovery that G4s can form in the G-rich regions from human
telomeric oligonucleotides in the late 1980s [7].
Early studies about the regulatory roles of promoter G4s have
focused on a few specific gene loci. For example, the formation of
G4 structures (mostly stabilised by certain G4-binding ligands) in
promoters of the human insulin [8,9],MYC [10,11], KRAS [12,13],
and PDGF-A [14] genes were shown to have significant influences
on downstream gene transcription activity. Subsequently, promot-
er G4s have been identified in important functional regions
(promoters, NHE regions, enhancers, and so on) of many other
cancer-related genes, and their biophysical properties in solution
have been thoroughly characterised. Examples include the G4s
found in promoters of KIT [15–19], RET [20], VEGF [21–24],
RB1 [25–27], BCL-2 [28–30], and HIF-1a [31] genes. These
isolated examples have led to the hypothesis that G4s may act as a
group of common cis-regulatory elements via various mechanisms
in vitro and in vivo. Indeed, accumulating bioinformatics studies in
the past decade supported this hypothesis as described below.
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Firstly, the enrichment and biased distribution of G4s are found
in gene transcription regulatory regions in the human genome,
such as in promoter regions, 59-ends of 59-UTRs, within the first
intron and within regions immediately downstream of the 39-ends
of genes. These findings indicate that these non-canonical DNA
structures are favoured by natural selection in the process of
evolution. Secondly, potential G4-forming motifs closely correlate
with functional regions in gene promoters in the human genome,
such as the gene regulatory elements [32] and G-rich TF
(transcription factor) binding sites [33,34], which further supports
the hypothesis that G4s are involved in gene transcription
regulation. Furthermore, the existence of potential G4-forming
motifs is also related with downstream gene expression levels,
indirectly demonstrating the regulatory roles of G4s in gene
transcription regulatory regions (TRRs) [35,36]. Finally, correla-
tion between prevalence of G4s and gene functions also indicates
potential roles of G4s in the human genome [37].
Due to its diverse biological functions and wide distribution in
the human genome, G4 DNA has attracted exceptional attention
from nucleic acid chemists to design and synthesise novel G4-
binding ligands that can interact efficiently and selectively with this
peculiar DNA structure. So far, most G4-binding ligands are
researched as potential anti-cancer agents by targeting cancer-
related G4s, especially the human telomeric G4 and oncogene
promoter G4s. The affinity and selectivity of G4-binding ligands to
G4s rather than to other DNA forms are mainly achieved by p–p
stacking and electrostatic interaction, which are also the two main
criteria in G4-binding ligand design [38,39].
To date, almost all G4 studies have focussed on their
involvement in cancer and therefore their potential as targets for
anticancer agents. Thus, most studies have centred on telomeric
G4 and promoter G4s in proto-oncogenes. Importantly, extensive
studies of these cancer-related G4s have contributed greatly to
forward our knowledge in this field, which have established the
fundamentals to investigate the role of G4s in other genes, such as
those involved in regulating cardiac functions. Since possible
biological functions of G4s have been identified in some heart-
related genes, such as PDGF-A, VEGF-A and HIF-1a, G4 research
also has relevance to cardiovascular science.
Taking into account the instability of G4s and their much lower
abundance as compared to adjacent duplex DNA in the human
genome in vivo, and the structural similarity between different G4s,
it makes the design of selective G4-binding ligands extremely
challenging, and off-target effects are practically inevitable.
However off-target effects may lead to multi-targeting effects in
some cases, which in turn become advantageous for G4-binding
ligands, and may enhance their therapeutic potential, such as the
ligand naphthalene diimide derivative 1 [40], 12459 [41–43], and
CX-3543 [44].
In this article, we first evaluated, by bioinformatics approaches,
the importance of G4s in TRRs of key cardiac genes as compared
to other genes, especially those involved in cancer. We found that
potential G4-forming motifs are particularly enriched in TRRs of
genes active in the heart, and TRRs of genes involved in cardiac
function-related pathways are also highly G4-abundant. Although
very basic, these findings clearly supported the hypothesis that G4s
are important in regulating cardiac function-related genes.
Furthermore, due to the abundance of G4-forming motifs in
TRRs of cardiac function-related genes, potentially, multi-
targeting strategy may have similar therapeutic potential as those
observed in anti-cancer research.
To validate the bioinformatics results (i.e. that G4s are involved
in regulating cardiac function-related genes) and to initially test the
multi-targeting strategy within a single gene, subsequently, the
human cardiac troponin I (TnIc) gene was selected as a model
system. Human TnIc is the only sarcomeric protein found to be
exclusively expressed in the cardiac myocyte, which makes it an
ideal model to investigate cardiac-specific gene expression and in
turn to provide new approaches to the construction of cardiac-
specific vectors in gene therapy. Although TnIc has been regarded
as a preferred biomarker in MI (myocardial infarction) diagnosis
for more than a decade [45,46], the molecular mechanisms of
human TnIc transcription regulation are still poorly understood,
and only a few TFs have been found to be involved in regulating
the transcription of TnIc [47–49]. This is partially due to the
difficulties in obtaining suitable cell models, and possibly due to
the extremely G-rich in its promoter. Indeed, TRR of TnIc is
highly G4-enriched according to the bioinformatics analysis.
Multiple G4-forming sequences have been identified in the
proximal promoter of human TnIc, and two types of G4-forming
motifs were selected for detailed studies, which are designated as
‘‘MNSG4’’ (between 2528 and 2319 bp upstream to the TSS,
transcription start site), and ‘‘280 G4’’ (centred at 280 bp to the
TSS). The MNSG4 motif is composed of 6 repeats of chromosome
19 specific G-rich minisatellite (MNS), which are highly conserved
in primates. Although conserved chromosome 19 specific MNS
repeats are also found in many other genes, such as the neuronally
expressed Shc adaptor homolog SCK1/SLI [50], the EFG-like
module-containing mucin-like receptor, EMR3 [51], the human
apolipoprotein C-II gene [52], and the human TnT [53], the
actual functions of this widely distributed G4-forming sequence
are still unclear. On the other hand, similar as the KIT1 G4-
forming sequence, the280 G4 is found to be unique in the human
genome [18]. More importantly, multiple putative or proven TF
binding sites are clustered within or around the 280 G4-forming
region, such as a CACC-box, an Sp1 binding site, an E-box, and a
GATA biding site [48].
We have used a combination of biophysical and biochemical
approaches to characterise the formation, stability and possible
regulatory roles of the G4s (MNSG4 and280 G4) in the promoter
of the human TnIc. The methods include CD (circular dichroism)
spectroscopy [3], EMSA (electrophoresis mobility shift assay) [7],
FRET (fluorescence resonance energy transfer) [54], DMS
(dimethyl sulfate) footprinting [31], FID (fluorescent intercalator
displacement) experiments [55], and dual luciferase reporter assays
[10] in HEK293 cell line. These methods are reviewed in [56] and
described in detail in [57]. It was found that these G4s have
comparable stability as that of proto-oncogene G4s, and they may
act cooperatively as enhancers in gene expression regulation in
HEK293 cells when they are stabilised by a synthetic G4-binding
ligand. This study provides the first evidence about the biological
significance of cardiac promoter G4s.
Materials and Methods
Enrichment of G4-forming Motifs in Different Tissues
Sequences of the human genome (version 37.64) were
downloaded from ENSEMBL FTP, and gene/transcripts features
were exported from BioMart (detailed protocols are described in
Protocols S1). TRR of individual transcripts were defined as
22,000 bp to +1,000 bp from TSS of the transcript. Although the
actual mechanisms and final consequences of downstream and
upstream (relative to TSS) G4s are different, we are only interested
in whether or not G4s are involved in regulating a particular gene
expression, and thus down- and upstream G4s are investigated
together in most cases in this study. G4-forming motifs were
identified as G$3(N1,7G$3)$3. Tissue-specific enrichment of G4-
forming motifs was defined as the percentage of genes active in
G-Quadruplexes in Cardiac Function-Related Genes
PLOS ONE | www.plosone.org 2 January 2013 | Volume 8 | Issue 1 | e53137
certain tissue (GNF/Atlas organism part) containing at least one
G4-forming motif in a certain region of the TRR (Equation 1)
Tissue{specific Enrichment of G4
~
No: of gene containing at least one G4
Total No: of gene active in the tissue
|100%
ð1Þ
Besides the full TRRs, enrichment of G4s was also analysed and
compared in the distal promoter region (22,000,2501 bp),
proximal promoter region (2500,21 bp), and downstream
region (TSS,+1,000 bp). The analysis was carried out in 10
iterations to consider transcript redundancy. Hence the tissue-
specific enrichment of G4-forming motifs was presented as mean
6 standard deviation (SD). In analysing specific tissue, differences
among iterations were evaluated by one-way ANOVA test, in
which P$0.05 represents that no significant difference was found.
Importance of G4s in Different Pathways
To evaluate the importance of G4s in individual transcript, two
scores, F and Q, were calculated respectively to reflect the
abundance and location significance of G4s identified in each
transcript. In the TRR of each transcript, the percentage of
nucleotides involved in G4 formation is defined as F values
according to Equation 2
F~
Pn
i~1
(gei{gsiz1)
T
|100% ð2Þ
where n is the number of G4s identified in the TRR (F=0 when
n=0), gsi and gei are the start and end positions of i
th G4 identified
in the TRR relative to the TSS in 59 to 39 direction, and T, the
length of TRR being searched, is fixed at 3,000 in this study.
Abundance of G4s on the coding strand, and template strand
were separately calculated and labelled as Fcd, and Fncd, (subscripts
cd: coding strand; ncd: noncoding strand). Overall abundance of
G4s, the Po (o: overall), were calculated as the sum of Fcd, and Fncd.
To genome-widely compare the abundance of G4s in TRRs of
different transcripts, F scores of all transcripts without redundancy
were calculated (one transcript was randomly picked when
multiple transcripts were reported from the same gene), and the
cumulative frequencies of F scores of all transcript were calculated
and denoted as CFcd, CFncd, and CFo. To reach a more stringent
criterion, transcripts with F scores equal to 0 were excluded when
calculating CF. Genes with transcript CF values higher than 50%
were regarded as G4-rich in their TRR, while those with
transcript CF values lower than 50% were regarded as G4-scarce.
Except for the G4 abundance, the location of individual G4 in a
particular TRR may also correlate with its biological significance.
As reported in previous genome-wide analyses, G4 was found to
be enriched in the promoter region between 2200 bp and TSS,
and peaked at around 250 bp to TSS in the human genome [58].
This positional bias of G4 distribution in human gene promoters is
believed to be a result of evolutionary pressure [59]. Most
promoter G4s with confirmed biological functions localize in this
region, such as KIT and MYC promoter G4s. Thus, another
indicator, the Q score, is introduced to evaluate the potential
location significance of G4s in particular TRR.
Following on the previously reported method [58], the
probability distribution of each TRR position relative to TSS
involved in G4 formation along coding and template (noncoding)
strands of all TRRs was calculated according to Equation 3
Wk~
Pm
j~1
aj,k
m
|100% ð3Þ
where Wk is the normalized probability of nucleotide in position k
of all TRRs involved in G4 formation, m is the total number of
transcripts analyzed. aj,k is the logical value of nucleotide in
position k of jth TRR; aj,k=1 when the nucleotide is involved in G4
formation, otherwise aj,k=0. G4 location significance score Q (Qcd,
Qncd and Qo for coding and template strand, and overall,
respectively; Qo =Qcd+Qncd) for the TRR of a particular transcript
was calculated according to Equation 4
Q~
Xn
i~1
Pge
k~gs
Wk
gei{gsiz1
ð4Þ
The cumulative frequencies of Q scores, CQ, were also calculated.
Similarly, transcripts with the zero Q scores were excluded. Genes
with both CF and CQ values higher than 50% were regarded as
G4-important genes, while those with both values lower than 50%
were regarded as G4-less-important.
Correlation between the CF and CQ scores on the coding,
template strand and both strands were also investigated. The
correlation coefficient was calculated according to Equation 5
rxy~
Pn
i~1
(xi{x)(yi{y)ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPn
i~1
(xi{x)
2 Pn
i~1
(yi{y)
2
s ð5Þ
in which xi and yi are the CF and CQ scores of the coding, template
strand or both strands at genome level, x and y are the
corresponding mean values CF and CQ scores at genome level.
CF and CQ were calculated for all transcripts without
redundancy. To evaluate bias introduced in random-picking when
multiple transcripts exist in one gene, calculation was carried out
for 10 iterations. Gene list for all pathways was downloaded from
KEGG database. All pathways including more than 50 genes were
subject to pathway analysis. When more than 50% component
genes in a pathway were calculated as G4-important (excluding
those with both CF and CQ equal to zero), the pathway was
regarded as G4-important. To evaluate the G4-importance of
individual pathway, distribution of CF and CQ values of pathways
were compared to the distribution of all transcripts in humane
genome by Wilcoxon rank sum test. Differences between iterations
of individual pathway were evaluated by one-way ANOVA test.
The source code of bioinformatics studies is available upon
request.
DNA Oligos
All labelled and unlabelled DNA oligos used in biophysical
studies were purchased from IBA Biotechnology (Go¨ttingon,
Germany) and HPLC purified (double HPLC purification for
labelled oligos). Fluorophores (Cy3 or Cy5) were coupled to
nucleotides via NHS (N-hydroxysuccinimide) esters. Oligo con-
centration was determined by absorption at 260 nm. Oligo
TrMNS-I is the consensus sequence of G4-forming minisatellites
between 2528 and 2319 bp to the TSS of human TnIc gene.
G-Quadruplexes in Cardiac Function-Related Genes
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Oligo TrMNS-II is the C-rich complimentary strand of oligo
TrMNS-I. Oligo TrMNS-III is the Cy3-labeled TrMNS-I attached
with a 34-mer artificial linker on its 39-end. Tr-80-I is a G4-
forming sequence from the noncoding strand fragment of human
TnIc promoter localized between 297 and 273 bp to the TSS,
while oligo Tr-80-II is its C-rich complimentary strand. Oligo Tr-
80-III is the Cy3-labeled Tr-80-I attached with a 34-mer artificial
linker on its 39-end. Oligo Comp-Cy5 is a Cy5-labeled oligo
complimentary to the 34-mer artificial linker in oligos TrMNS-III
and Tr-80-III. Oligos and primers used in plasmid construction
were purchased from Eurofins MWG Operon (Ebersberg,
Germany) and were subjected to HPLC purification. The
sequences and labeling sites of these oligos are listed in Table 1.
Formation of G4s in Solution
Formation of G4s was determined by EMSA, CD spectroscopy,
and DMS footprinting in solution. Detailed protocols are
described in Protocols S1.
G4 Unfolding Thermodynamics and Kinetics
Unfolding thermodynamics of G4s and the stabilising ability of
G4-binding compounds to these G4s were investigated by CD
melting experiments. Unfolding kinetics of these G4s were
investigated via a pseudo-first order approach as described
previously [60]. Briefly, the fluorophores-labeled unfolded G4s
were trapped by excess C-rich oligos, and hence resulted in
decreased FRET signals. Detailed protocols are described in
Protocols S1.
G4-ligand Interaction in Solution by FID (Fluorescent
Intercalator Displacement) Assay
The corresponding oligonucleotides were first dissolved in
MilliQ water to yield a 20 mM stock solution, and then were
diluted in 10 mM potassium cacodylate (pH 7.4)/50 mM potas-
sium chloride (60 mM K+) buffer to the appropriate concentra-
tions. Prior to use in the FID assay, the DNA strands were
incubated to allow the formation of G4s as stated above. The
compounds to be analysed and thiazole orange (TO) were
dissolved in DMSO to give 1 mM stock solutions. The
corresponding solution was then diluted using 10 mM potassium
cacodylate (pH 7.4)/50 mM potassium chloride (60 mM K+)
buffer to the appropriate concentrations. The FID assay was
carried out according to the protocol as previously reported [55].
Briefly, to a mixture of DNA sequence (0.25 mM) and TO
(0.50 mM) in 10 mM potassium cacodylate (pH 7.4)/50 mM
potassium chloride (60 mM K+) buffer an increasing amount of
the molecule under study was added (0.125 to 5 mM, which
corresponds to 0.5 to 20 equiv). After an equilibration time of
3 min the emission spectrum was recorded between 510 and
750 nm with an excitation wavelength of 501 nm. This was
recorded using a Varian Cary Eclipse Spectrometer (Agilent
Technologies, Yarnton, UK). The fluorescence area was calculat-
ed using the ‘‘trapezium rule’’ method. The area was converted
into percentage TO displacement by the following formula: % TO
displacement = 100 2 [(fluorescence area of sample/fluorescence
area of standard)6100]. The standard fluorescence spectrum was
obtained in the absence of any G4-binding ligands. % TO
displacement was then plotted against each of the compound
concentrations to give the respective FID curves, from which the
DC50 values were determined.
Table 1. Details of oligos used in biophysical studies in solution.
Name Sequence (59–39)
Synthetic oligos used in biophysical studies
TrMNS-I TGG GTC TGA GGG AGG AGG GGC TGG GGG C
TrMNS-II GCC CCC AGC CCC TCC TCC CTC AGA CCC A
TrMNS-III
Cy3TGG GTC TGA GGG AGG AGG GGC TGG GGG CGA GGT AAA AGG ATA ATG GCT ACG GTG CGG ACG GC
TrMNS-IV
Cy3TGG GTC TGA GGG AGG AGG GGC TGG GGG Cy5C
Tr-80-I CGG GGG CGC GTG AGG GGC GGG GTG GGC
Tr-80-II GCC CAC CCC GCC CCT CAC GCG CCC CCG
Tr-80-III
Cy3CGG GGG CGC GTG AGG GGC GGG GTG GGC GAG GTA AAA GGA TAA TGG CTA CGG TGC GGA CGG C
Tr-80-IV
Cy3CGG GGG CGC GTG AGG GGC GGG GTG GG Cy5C
Comp-Cy5 GCC GTC CGC ACC GTA GCC ATT ATC CTT Cy5TTA CCT C
Synthetic oligos used in plasmid construction
MNS_G CCT GGA CTC TTG GGT CTG AGG GAG GAG GGG CTG GGG G
MNS_C TCC AGG CCC CCA GCC CCT CCT CCC TCA GAC CCA AGA G
MNSM_G CCT GGA CTC TTG AAT CTG AGA GAG GAG AGA CTG AGA G
MNSM_C TCC AGG CTC TCA GTC TCT CCT CTC TCA GAT TCA AGA G
59Linker_G GGG GAC AAG TTT GTA CAA AAA AGC AGG CTG AAT TC
59Linker_C TCC AGG GAA TTC AGC CTG CTT TTT TGT ACA AAC TTG TCC CC
39Linker_G CCT GGA CAC TTG AGT CTG CAG ACC CAG CTT TCT TGT ACA
AAG TGG TCC CC
39Linker_C GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC TGC AGA CTC
AAG TG
Note: Cy3/5N indicates a Cy3 or Cy5-labeled nucleotide, which is coupled via NHS ester.
doi:10.1371/journal.pone.0053137.t001
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Construction of Wild-type/Mutated Minisatellite
Concatemer
Engineered wild-type (E-WT, oligo MNS_G/C) and mutated
(M, oligo MNSM_G/C) minisatellite concatemers were con-
structed by ligation and recombination processes. Oligos
MNS_G/C and MNSM_G/C were first phosphorylated indi-
vidually in 10 ml phosphorylation reaction system (DNA
250 pmol; 106 PNK buffer, 1 ml; 10 mM ATP, 1 ml; 10 U/ml
PNK, 0.5 ml) at 37uC for 1 hour. Then, phosphorylated oligos
MNS_G/C andMNSM_G/C were annealed to each other by a
PCR thermocycler (Stratagene) at 95uC for 5 min, then gradually
cooling to 25uC over 2 hours. Concatemers with random number
of repeat were constructed by self-ligation (first round ligation) of
annealed single repeat of E-WT/M minisatellites. 59linker and
39linker were phosphorylated and annealed from oligos 59Lin-
ker_G/C and 39Linker_G/C respectively through the same
protocol. Then, annealed 59linker was ligated to concatemers in a
second round ligation, and the 39linker was added in the third
ligation subsequently. All three rounds ligation were carried out in
20 ml system at 16uC for 2 hours. Ligation products larger than
100 bp were extracted by QIAGEN Gel extraction kit after each
round of ligation. All enzymes and buffers used in this step were
purchased from NEB (Hitchin, UK).
Construction of Luciferase Vector
Entry vector containing minisatellite concatemers was made
by recombinating the third round ligation products into
pDONR221 using GatewayH BP reaction kit (Invitrogen). The
minisatellite concatemers were further recombinated into a
pGL3-Basic-Gateway vector using GatewayH LR reaction kit
(Invitrogen). The insertions were confirmed by sequencing using
M13 primer pair. The 2299 to +51 fragment of human TnIc
promoter was PCR amplified from plasmid pGL3-Basic_2553
containing the 2553 to +69 fragment of human TnIc. Plasmid
pGL3-Basic_2553 is a kind gift from Dr. Nigel Brand. Vectors
hTnIc-6MNS(E)-WT, hTnIc-3MNS(E)-WT, and hTnIc-
1MNS(E)-WT plasmids were constructed by inserting the
2299 to +51 fragment into pGL3-Basic-Gateway vectors
downstream to the engineered WT minisatellite concatemers
with 6 repeats, 3 repeats, and 1 repeat via PstI and XhoI
restriction sites. By using similar approach, the vector containing
6 repeats of mutated MNSG4 was constructed as hTnIc-6MNS-
M. Vector hTnIc-299-WT was constructed by inserting the
2299 to +51 fragment into empty pGL3-Basic-Gateway vector
via EcoRI and PstI restriction sites. Vectors hTnIc-80 G4-M,
hTnIc-80Sp1-M, and hTnIc-80 G4/Sp1-M were derived from
hTnIc-6MNSG(E)-WT by DpnI-mediated site-direct mutagene-
sis, in which the 280 G4-forming sequence, the Sp1 binding
site in the 280 G4 motif, and both of them were mutated
respectively. An overall mutant hTnIc-6MNS/80 G4-M was
generated from hTnIc-6MNS-M by mutating both 280 G4-
forming sequence and the Sp1 binding site in it. Vectors are
schematically illustrated in Figure 1.
Transfection of Cultured Human Cells and G4-binding
Ligands Treatment
HEK293 cells were inoculated in 75 cm2 flasks and grown to
70–80% confluence at 37uC and under 5% CO2 atmosphere in
complete medium (Dulbecco Modified Eagle’s Medium
(DMEM) supplemented with 4500 mg/L D-glucose, 5.0 mM
L-glutamine, 10% fetal calf serum, and 83.3 U/ml of penicillin
and streptomycin (Invitrogen)). The cells were harvested by
Trypsin-EDTA, and reseeded 26104 cells/well in 24 well plates
with a volume of 300 ml/well complete medium, and the cells
were cultured overnight. The medium was replaced by 300 ml
fresh medium at least 2 hours before transfection. Transfection
was carried out by following calcium phosphate precipitation.
Briefly, 20 ng pRL-TK control plasmid (Renilla luciferase
reporter vector driven by herpes simplex virus thymidine kinase
promoter PHSV-TK) and 150 ng testing pGL3 luciferase plasmid
was transfected in each well, and cells were incubated with
precipitated DNA for another 24 hours before adding G4-
binding ligands. G4-binding ligands were diluted in DMSO to
different concentrations as 10006 stock solution. 0.3 ml G4-
binding ligand stock solution was diluted to 300 ml by fresh
medium to replace the transfection medium in each well. Cells
were then incubated with G4-binding ligands for 24 hours
before cell lysis for luciferase assays. Experiments were carried
out in triplicates.
Luciferase Assay
Transfected cells were firstly washed by ice-cold PBS to reduce
background signals from the medium, and luciferase assays were
performed subsequently according to manufacturer’s instruction
(Promega). Generally, cells were lysed by 100 ml passive lysis buffer
per well, and 10 ml cell lysate were added to 50 ml luciferase assay
reagent. After 3 s’ delay, luciferase signals were collected for 10 s
in a Glomax 20/20 luminometer (Promega). After adding 50 ml of
Stop and Glo reagent, Renilla signals were collected for 10 s as
internal control.
Results
Enrichment of G4 DNA in the Heart
The enrichment of G4s in the transcriptional regulatory regions
(TRRs: 22,000 bp to +1,000 bp around Ensembl Transcript
Start) of all known protein-coding genes was first analysed as a
reference point. In total, of 19,633 genes that were analysed,
67.7960.01% of them were found to contain at least one G4 on
both coding strand and template strand, with 52.4260.02% and
46.9160.02% containing at least one G4 on the coding strand
(G4) and template strand (C4), respectively. Compared with the
widely accepted results that around 40% human gene promoters
contain G4s [6], the much higher percentage (67.7960.01%)
identified here can be attributed to the much longer region around
the TSS that was analysed in this study. Similar results have been
previously reported in the chicken genome when regions of similar
length were analysed [61].
The enrichment of conserved G4s in different tissues has been
previously investigated by Verma et al. [35]. Following a similar
method, we focused on investigating the enrichment of G4s in
different regions of gene TRR in different tissues (different GNF/
Atlas organism) in the human genome. As shown in Figure 2 and
Table S1, G4s are highly enriched in the whole TRR of genes
active in the lung, heart and brain including cerebellum peduncles
and caudate nucleus. The high G4 enrichment in these tissues may
indicate that these tissues have evolved certain mechanisms to
utilize G4s to regulate gene transcription (i.e. providing binding
sites for tissue-restricted TFs, maintain the separation of coding
and template strands, and so on), or at least to avoid possible
negative effects caused by the formation of G4s in TRR (i.e. to
resolve folding of G4 by helicases). For tissues with the lowest G4
enrichment at the whole TRR level, corresponding G4 enrich-
ment in different regions of TRR is also among the lowest.
Interestingly, for some tissues, although moderate or relatively low
G4 enrichment was found at whole TRR level, G4s were found to
be enriched in either distal or proximal promoters in the TRRs.
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Figure 1. Structure of human TnIc gene promoter and constructed luciferase expression vectors. (a) Schematic illustration of the G4-
forming motifs in the promoter of human TnIc gene. (b) the structure of luciferase expression vectors driven by engineered human TnIc promoters.
doi:10.1371/journal.pone.0053137.g001
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For example, in smooth muscle, although the overall G4
enrichment is only moderately higher than that found at the
whole genome level, its G4 enrichment in the proximal promoter
region is among the highest. Similar phenomena were found in
tissues of adipose, olfactory bulb, and fetal thyroid (Table S1). This
may indicate that in these tissues certain mechanism may exist to
utilize G4s in the proximal promoter region, but not in other
regions.
According to the above findings, several points became
apparent. Firstly, enrichment of G4 in TRR of genes has a
strong tissue-specificity. Secondly, in some tissues (smooth
muscle, adipose tissue, olfactory bulb, and fetal thyroid), G4s
are enriched specifically in certain regions of TRRs (location-
specificity) reflecting possible tissue-related regulatory roles of
G4s. These tissues, with either tissue- or location-specific
enrichment of G4s in TRRs, are worthy of further investigation
in the future.
From the studies described here, G4s appear to be highly
abundant in TRRs of genes active in the cardiac function-related
tissues, such as the heart and smooth muscle. To further
investigate the biological significance of G4s in the heart, we
analysed the abundance and location significance of G4s in TRRs
of genes involved in different pathways described within the
KEGG (Kyoto Encyclopedia of Genes and Genomes) PATHWAY
database, especially those related to cardiac functions. The
importance of G4s in each TRR was evaluated by two scores:
G4 abundance score (F score, and its cumulative frequency: CF)
and G4 location significance score (Q score, and its cumulative
frequency CQ), which will be described separately in following
sections.
F Score
As compared to duplex DNA, G4s are normally less stable
(reviewed in [4,62,63]). Thus, high G4 content (abundance) in a
particular TRR can enhance the competition of G4 DNA with
Figure 2. Enrichment of G4s in TRRs of genes active in different tissues. The percentage of genes active in different tissues containing at
least one G4-forming sequence in the whole TRR (black), 22,000,2501 bp of TRR (red), 2500,21 bp of TRR (green), and TSS,+1,000 bp of TRR
(blue). Enrichment of G4s in all protein-coding genes (G4 enrichment at genome level) is indicated by the red arrow. The calculation was repeated
randomly for ten times (multiple transcripts of one gene were randomly chosen for ten times) to take into account the redundancy effects of multiple
transcripts.
doi:10.1371/journal.pone.0053137.g002
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adjacent duplex DNA, resulting in the increased probability of the
involvement of G4s in regulating downstream gene expression.
Based on this assumption, the F score representing the abundance
of G4s in a particular TRR was used as the first indicator to
evaluate the importance of G4 in the TRR of each gene (methods
modified from Eddy et al. [37]). For each transcript, the F score
was calculated based on the percentage of nucleotides involved in
G4 formation in the TRR of that transcript (Equation 2). By
including all transcripts with redundancy, the coding strand,
template strand (non-coding strand), and both strands were
analysed separately to give the Fcd, Fncd, and Fo scores, respectively
(Table 2). Figure S1 shows the distribution of these F scores
obtained by including all transcripts with redundancy. A similar
skewed distribution of G4 abundance was reported previously in
an analysis showing G4 formation potential (G4P) in RefSeq of
genes [37]. However, due to the higher resolution in this study
(using the percentage of nucleotides involved rather than the
percentage of a shifting searching window containing G4-forming
motifs), two peaks were found in the distribution of G4 abundance
scores. By comparing the peak position and corresponding values
in the distribution histograms of G4 abundance on coding and
template strand (Figure S1 a and b, lower graphs), G4-forming
motifs are more enriched in the coding strand. All values were re-
calculated with 10 iterations with randomly chosen transcripts,
and compared with values from transcripts with redundancy, and
similar results were obtained (Table 2). The CFcd, CFncd, and CFo
values for each transcript were calculated as the cumulative
frequency according to the Fcd, Fncd, and Fo histograms (Figure S1,
upper graphs).
Q Score
Besides the abundance, the locations of G4s in a particular
TRR are also important in estimating the potential biological
significance of G4. For example, Du et al. suggested that the
colonization of G4-forming motifs with TF binding sites in the
proximal promoters indicates potential regulatory roles of G4s
[32]. Thus, we believe that the biased probability distribution of
G4-forming motifs in TRRs at whole genome level, which was
reported by Huppert et al. [58], may reflect the preference of
G4 location in TRRs through evolution. Following Equation 3
(modified from Huppert et al. [58]), the probability distribution
histogram was generated (Figure S2 a). Similar probability
distribution of G4 around TSS has been reported in the
genomes of other warm-blooded animals [59]. The location and
strand polarity-dependent distribution of G4s appears to reflect
an evolutionary pressure, and it is necessary to take into
account the location of G4 motifs when considering their
importance in the TRR of a particular gene. Therefore, a
location significance score Q was introduced in order to
characterise the location significance of G4s. For each TRR,
its G4 location significance scores on the coding (Qcd) and
template (Qncd) strand were calculated according to Equations 3
and 4. The overall G4 location significance score (Qo) was
determined as the sum of Qcd and Qncd. Histograms Qcd, Qncd,
and Qo for TRRs of all transcripts with redundancy are shown
in Figure S2 b,d (lower graphs). The larger maximum,
median, and average Q scores on the coding strand also reflect
the higher location significance of G4s on the coding strand as
compared to the template strand. Transcripts without redun-
dancy were also analysed with 10 iterations of randomly chosen
transcripts, and similar results were obtained as compared to the
results from transcripts with redundancy (Table 3). The CQ
values for each transcript were calculated as its cumulative
frequency in Q histogram and are shown in Figure S2 b,d
(upper graphs).
Correlation between G4 Abundance and G4 Location
Scores
The correlation between CF and CQ scores (abundance and
location significance of G4s in TRRs) were evaluated. As shown in
Figure S3, CF and CQ are plotted as correlation maps. According
to the maps, CF values are positively correlated to CQ values.
Particularly, in G4-important TRRs (TRRs with both values
higher than 50%), their G4 abundance is more positively
correlated to their G4 location significance as compared to G4-
less-important TRRs (TRRs with both values lower than 50%). To
investigate whether this positive correlation of G4-important
TRRs is only caused by the increase of G4 content or not, G4s
found in different regions of TRRs were subjected to further
investigation. The total number of G4s identified in different
regions in G4-important and G4-less-important transcripts were
counted and normalised to the length of different regions. If the
increase of CQ, the location significance score, was solely
dependent on the increase of CF, the G4 abundance score, then
the proportion of the normalised total number of G4 found in
different regions should be in constant between G4-important and
G4-less-important TRRs. We found that the proportion of G4s
Table 2. Comparison of G4 abundance in TRRs of transcripts
(the F score).
Median Value Mean Value Max Value
Transcripts with Redundancy (46,205 Transcripts)
Fcd 1.6 2.1 33.2
Fncd 1.4 1.9 29.6
Fo 2.2 2.9 33.2
Transcripts without Redundancy (19,633 Transcripts), 10 iterations*
Fcd 1.5560.02 2.0360.01 33.2
Fncd 1.4260.02 1.9360.01 25.8863.96
Fo 2.1360.01 2.9060.01 33.2
*The Fcd, Fncd, and Fo values from 1
st iteration were used as templates and
compared with those from following iterations by one-way ANOVA test. No
differences among iterations were observed (P$0.05).
doi:10.1371/journal.pone.0053137.t002
Table 3. Comparison of G4 location significance in TRRs of
transcripts (the Q score).
Median Value Mean Value Max Value
Transcripts with Redundancy (46,205 Transcripts)
Qcd 2.5 3.3 26.9
Qncd 1.7 2.3 19.8
Qo 3.2 4.2 29.3
Transcripts without Redundancy (19,633 Transcripts), 10 iterations*
Qcd 2.4860.02 3.1360.02 23.461.6
Qncd 1.8560.02 2.4060.02 19.760.2
Qo 3.2060.02 4.0760.01 28.360.2
*The Qcd, Qncd, and Qo values from 1
st iteration were used as templates and
compared with those from following iterations by one-way ANOVA test. No
differences among iterations were observed (P.0.23).
doi:10.1371/journal.pone.0053137.t003
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found in the proximal promoter region (2500 bp to 21) was
increased by 20% from less G4-important TRRs to G4-important
TRRs (Figure 3). This indicates that the larger CQ value in G4-
important TRR reflects the combined effects of increased total
number of G4s and particularly the increased number of G4 in key
promoter regions (with the high Wk values). Most well-studied
genes containing promoter G4s with potential regulatory functions
are in the group of G4-important transcripts in the correlation
map, including MYC, VEGF-A, BCL-2, HIF1-a, MYB, PDGF-A,
PDGFR-b, KRAS, and TERT (Table S2). One interesting exception
is KIT, with CFo and CQo of 43.5% and 73.4%. This may suggest
that G4 location might be more relevant than the abundance of
G4 in evaluating potential biological significance of G4s in a TRR.
G4-important Pathways
All pathways composed of more than 50 genes available in
KEGG PATHWAY database were extracted, and CFo and CQo
values of each gene in a particular pathway were calculated. For
genes with multiple transcripts, one transcript was picked
randomly, and genes with both values (CFo and CQo) equaling to
zero were excluded. Then, in each pathway, percentages of genes
with TRRs having both CFo and CQo values higher than 50%
were counted. Pathways with more than 50% genes’ transcripts
identified as G4-important were regarded as G4-important
pathways as listed in Table 4. Ten iterations were carried out to
evaluate effects from transcripts redundancy. For all pathways, no
significant difference was found in CFo and CQo values among
iterations of each individual pathway (one-way ANOVA test,
P$0.05). Based on this criterion, G4-important pathways could be
grouped into six categories with distinct functions. As shown in
Table 4, the first category is cancer-related pathways where G4s
are enriched in proto-oncogenes, in accordance with previously
reported results [37]. Given the fact that G4s are enriched in
cancer-related pathways, it is not difficult to understand why the
off-target effects of certain G4-binding ligands with anti-cancer
potential could well bring some benefits in anti-cancer therapy,
such as the G4-binding fluoroquinolone derivative Quarfloxin
[44], and the naphthalene diimide derivative 1 [40]. The second
category is signaling pathways such as those involving VEGF,
Wnt, Hedgehog, and MAPK (mitogen-activated protein kinase),
which have key component containing promoter G4s with possible
regulatory functions. Pathways related to cell junction, neuron
function, and bacterial infection are also found to be G-important.
The last category, heart function-related pathways, is found to be
highly G4-important. There are seven pathways in the KEGG
PATHWAY database involved in cardiac functions or heart
diseases, while six of them are identified as highly G4-important.
These pathways are not only involved in normal heart function
such as calcium signaling and muscle contraction, but also in
various cardiomyopathies, making targeting promoter G4s at
pathway level rather than in single gene an attractive strategy (the
multi-targeting strategy) in the treatment of certain cardiovascular
diseases.
Based on the high importance of G4s in cardiac function related
pathways, we assume that G4s might function as a general
regulatory element in cardiac related genes. To validate our
bioinformatics results and our assumption, we have chosen human
cardiac troponin I (TnIc) as a model system to investigate possible
biological functions of cardiac promoter G4s. As one of the central
components in cardiac muscle contraction pathway, TnIc is also
involved in most heart function related pathways. Furthermore,
TRR of cTnI is highly G4 important according to our
bioinformatics analysis (CFo 92.6%, and CQo 95.2%). In the
promoter of human TnIc, two types of G4-forming motifs were
identified, which are designated as ‘‘MNSG4’’ (between 2528 and
2319 bp upstream to the TSS), and ‘‘280 G4’’ (centred at
280 bp to the TSS) (Figure 1 a). Both MNSG4 and 280 G4 are
characterised in solution and in HEK293 cells and the results are
shown below.
Evidence of G4s Formation in Solution
EMSA experiments were first used to probe the formation of
G4s in the unlabeled MNS and 280 G4-forming sequences from
the promoter of human TnIc. The fast migrating band of MNSG4-
forming sequences (oligos TrMNS-I) in native gels indicated that
intramolecular G4(s) is the only conformation at 5 mM oligo
concentration. However, at similar concentration, slow migrating
bands of280 G4-forming sequence (oligo Tr-80-II) were observed
Figure 3. The normalised percentage of G4s in different regions of TRRs of G4-less-important and G4-importance transcripts. (a) By
normalising to the total length of different regions, 17.7%, 40.6%, and 41.7% G4s were found in the Region I (distal promoter,22,000,500 bp, black),
II (proximal promoter, 2500,21 bp, red) and III (downstream region, TSS,1,000 bp, green) in TRRs of G4-less-important transcripts. (b) By
normalising to the total length of different regions, 13.0%, 48.5%, and 38.5% G4s were found in the Region I (distal promoter, black), II (proximal
promoter, red) and III (downstream region, green) in TRRs of G4-important transcripts. The proportion of G4s found in Region II, the proximal
promoter region increases by 20% from G4-less-important to G4-important TRRs.
doi:10.1371/journal.pone.0053137.g003
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in a native gel, indicating it can adopt a mixture of intramolecular
(the major form, 60% according to band intensity) and intermo-
lecular G4s. EMSA results are shown in Figure S4.
Comparative CD spectra analysis was also used to provide
primary evidence of the formation and general conformations of
both MNSG4 and 280 G4 in solution. Briefly, a single repeat of
MNSG4 (oligo TrMNS-I) may adopt parallel structure(s) in LiCl
solution. In KCl solution, it is very likely that the majority of single
repeat of MNSG4 adopts a similar folding pattern as the TBA
(thrombin binding aptamer) and forms an anti-parallel G4 (or G4s)
[64,65] (Figure 4 a). For the 280 G4, the 280 G4-forming
sequence (oligo Tr-80-I) may adopt a hybrid parallel/anti-parallel
structure similar to the BCL-2 Pu39WT in LiCl solution [30],
while in NaCl and KCl solutions, it adopts typical parallel
conformation (Figure 4 b). However, as an empirical method, CD
spectra are not conclusive to confirm the existence of G4s in
solution [66]. Indeed, CD spectra with a peak at 260 nm and a
trough at 240 nm, which is believed to represent the existence of
parallel G4s, can also be observed in duplexes, hairpins and single-
stranded DNA samples [67]. Thus, to further confirm the
existence of both MNSG4 and 280 G4, fast migrating bands
Table 4. KEGG pathways with high G4-importance.
KEGG
Pathway ID Pathway Description
% of High CFo
and CQo No. of Gene
% of Gene with G4
in TRR
Pmax of
CQo* Pmax of CFo*
Cancer-related pathways
hsa05210 Colorectal cancer 57.964.5 62 86.362.2 6E-4 0.001
hsa05211 Renal cell carcinoma 57.663.3 71 83.962.8 7E-4 0.003
hsa05213 Endometrial cancer 56.963.7 52 84.863.1 0.019 0.037
hsa05217 Basal cell carcinoma 53.762.9 55 93.861.3 4E-5 6E-6
hsa05200 Pathways in cancer 53.561.3 327 82.561.4 3E-11 3E-11
hsa05223 Non-small cell lung cancer 53.562.6 54 86.963.1 0.003 0.02
Signaling pathways with promoter G4s in key components
hsa04340 Hedgehog signaling pathway 60.963.4 56 87.361.8 2E-4 1E-4
hsa04370 VEGF signaling pathway 60.763.0 80 87.962.1 8E-6 1E-4
hsa04010 MAPK signaling pathway 59.561.5 271 83.561.3 7E-16 1E-16
hsa04310 Wnt signaling pathway 58.962.5 150 89.960.9 2E-12 4E-12
Cell junction-related pathways
hsa04520 Adherens junction 67.064.2 72 81.361.6 2E-5 6E-5
hsa04510 Focal adhesion 56.961.3 199 80.461.3 4E-8 8E-8
hsa04810 Regulation of actin cytoskeleton 55.762.4 213 79.162.3 3E-6 2E-5
hsa04530 Tight junction 53.962.1 129 77.061.8 8E-4 5E-4
hsa04540 Gap junction 53.862.0 88 86.161.9 8E-5 6E-5
Neural cell regulation-related pathways
hsa04724 Glutamatergic synapse 61.861.6 129 87.161.6 5E-9 7E-9
hsa04360 Axon guidance 61.062.7 128 86.762.2 4E-9 4E-9
hsa04720 Long-term potentiation 60.262.0 70 90.661.2 1E-6 8E-6
hsa04722 Neurotrophin signaling pathway 55.662.1 125 88.961.9 4E-8 1E-7
hsa04912 GnRH signaling pathway 55.561.3 104 85.961.7 1E-6 1E-6
Bacterial infection-related pathways
hsa05130 Pathogenic E.coli infection 58.664.9 55 82.763.8 0.004 0.008
hsa05131 Shigellosis 55.863.4 62 86.362.3 8E-5 2E-4
hsa05100 Bacterial invasion of epithelial cells 54.562.8 71 82.463.7 0.006 0.01
Heart function-related pathways
hsa05412 Arrhythmogenic right ventricular
cardiomyopathy
60.063.5 73 80.163.5 0.004 0.01
hsa05410 Hypertrophic cardiomyopathy 57.563.1 83 77.162.7 0.01 0.04
hsa05414 Dilated cardiomyopathy 57.263.1 90 78.262.8 0.009 0.02
hsa04020 Calcium signaling pathway 54.462.1 178 83.161.5 5E-6 5E-6
hsa04260 Cardiac muscle contraction 54.263.0 72 73.262.9 0.1 0.4
hsa04270 Vascular smooth muscle contraction 53.861.0 121 85.261.8 1E-7 9E-7
*Pmax values are calculated by comparing the CQo and CFo scores of genes from individual pathways with those from all transcripts without redundancy in each iteration
by Wilcoxon rank sum test. P#0.05 means the G4 abundance (CFo) or location significance (CQo) of gene involved in the pathway is significantly different from those at
genome level. For all pathways, no significant difference was found in CFo and CQo values among iterations of each individual pathway (one-way ANOVA test, P$0.05).
doi:10.1371/journal.pone.0053137.t004
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from EMSA experiments (in the presence of 100 mM K+) were
extracted and subjected to DMS footprinting.
According to the different protection effects in DMS footprint-
ing, a preferred folding pattern of MNSG4 is proposed as
G3N5G3N5G3N2G3, while for the 280 G4 multiple folding
patterns may coexist with first loop ranging between 7,10
nucleotides, and second and third loops ranging between 1,2
nucleotides (Figure S5). Both of them are distinct from the general
folding pattern of promoter G4s indentified in cancer-related
genes. Although the exact G4 structures of MNSG4 and 280 G4
cannot be proposed based on DMS footprinting results alone,
those fully protected guanines in both sequences clearly indicate
the formation of G4s.
Thermal Denaturation of MNSG4 and 280 G4 Measured
by CD Melting
CD melting experiments were used to investigate the thermal
stability of these G4s in the presence of 100 mM K+. For the
MNSG4 (oligo TrMNS-I), by fitting the melting curve obtained at
295 nm, the melting temperature and unfolding enthalpy and
entropy of the anti-parallel MNSG4 were derived to be
71.460.5uC, 170611 kJ mol21 and 494631 J mol21 K21
respectively by a model as previously reported (Figure S6 a). For
the 280 G4 (oligo Tr-80-I), the parallel G4 with lower thermal
stability, which accounts for 57.3% of CD signals at 263 nm, was
almost fully denatured at 90uC, while no denaturing was observed
for the other parallel species with high thermal stability. Since it
has been shown by EMSA experiments that about 40% of the280
G4 is able to adopt an intermolecular G4 conformation at 5 mM
concentration, it is likely that the undenatured parallel species
corresponds to intermolecular parallel G4s (Figure S4 b and S6 b).
Unfolding Kinetics of MNSG4 and 280 G4 Measured by
FRET
Two subpopulations with different unfolding behaviors were
revealed by fitting the unfolding curves of MNSG4, (Figure 5 a
and Table S3). The fast hybridised subpopulation is believed to be
partially folded or randomly coiled oligos with hybridisation rate
constant around 0.46104 M21s21. As compared to a typical
hybridisation rate constant, which is around 105 M21s21, the
much slower hybridisation rate constants observed here clearly
indicated that the C-rich oligos still need to unfold certain unstable
structures before fully hybridising the partially unfolding G-rich
strand. The slow decaying component represents the unfolding
process of MNSG4. As compared to the KIT1 G4 studies that
used a similar system [68], the MNSG4 is more kinetically stable
at high temperature (time constants of KIT1 G4 at 45 and 50uC
are 2,300 and 1,000 s respectively), which echoes the higher
thermal stability of MNSG4 in single-stranded form. The
activation energy of the unfolding of MNSG4 was determined as
22.160.4 kJ mol21 by Arrhenius equation (Figure S7 a and Table
S3), and the activation enthalpy and entropy were derived by
Eyring equation as 19.660.4 kJ mol21, and 2249.261.2 J mol21
respectively. This relatively low activation energy/enthalpy and
very negative entropy indicates that the unfolding of MNSG4 is
entropically driven, and this may suggest that the MNSG4 unfolds
through a ‘‘pre-organized’’ transition state, which possibly relates
to the long loops in the folded MNSG4 (two 5-nucleotide adjacent
loops). In the process of MNSG4 opening, these fluctuating long
loops may partially anneal to the C-rich strand, resulting in a series
of relatively ‘‘ordered’’ intermediates with negative entropy, and
the invasion of C-rich strand may further destabilise the folded G4
structures without transiting G4 into other partially unfolded
structures (more disordered structures with positive entropies).
Similar experiments were carried out on the TnIc 280 G4, and
two subpopulations (fast and slow unfolding components) were
revealed with different kinetic behaviours (Figure 5 b, Table S3).
The fast-unfolding 280 G4 (280 G4-F) exhibits comparable
kinetic stability to the MNSG4, while the slow-unfolding 280 G4
(280 G4-S) is at least 30-fold more stable than the 280 G4-F, and
of similar stability as the KIT2 G4 studied previously by using an
identical method [68]. Both 280 G4-F and 280 G4-S were
characterised by a large activation enthalpy and small unfavoured
activation entropy, suggesting the existence of more significant
enthalpic barriers (Figure S7 b and Table S3). As compared to the
MNSG4, only one long loop was found in the 280 G4 (the first
Figure 4. CD spectra of the two promoter G-quadruplex sequences in solutions containing different salts. (a) single-repeat MNSG4. (b)
280 G4.
doi:10.1371/journal.pone.0053137.g004
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loop, length between 10,7 nucleotides), and correspondingly less
negative activation entropies were identified in unfolding processes
of the 280 G4. As the 280 G4-F has a more negative DS{ than
the 280 G4-S, the destabilising contribution from the loop
(partially annealed more ordered states) of 280 G4-F is more
prominent than that from 280 G4-S, and thus less energy is
required for the 280 G4-F to reach the transition state for the full
hybridisation to happen. Indeed, a smaller DH{ of 280 G4-F was
also found.
Stabilisation of MNSG4 and 280 G4 by Synthetic G4-
binding Ligands
Once it was established that these sequences can indeed form
quadruplex structures, it was of interest to determine whether
small molecules could facilitate the formation and stabilise the
quadruplex structure. Over the past few years some of us have
demonstrated that metal-containing compounds (where the metal
is tightly bound to an organic ligand) can be excellent quadruplex
DNA binder [55,69]. Therefore, we evaluated the ability of three
of these metal compounds (compound 1–3, Figure 6) to stabilise
the quadruplex structures in the MNSG4 and 280 G4 sequences.
The compounds were selected since they were found to be
stronger quadruplex binders via a combination of P–P end-
stacking interactions (with the terminal guanine tetrad) and
electrostatic interactions (with the loops and grooves of quad-
ruplexes) [55].
We first determined their relative binding affinity towards both
quadruplexes via the well-established Fluorescent Intercalator
Displacement (FID) assay. The results, which are summarized in
Table 5, show that the two di-metallic compounds (2 and 3) bind
strongly to MNSG4 with DC50 values under the 0.5 mM
threshold for good binders. The mono-platinum compound 1,
also displays some interaction but its DC50 value is twice as big as
those of 2 and 3. Interestingly, there is a wider range of binding
affinities towards the 280 G4 quadruplex with the di-copper
compound (3) displaying a very low DC50 (i.e. strong binding),
reasonably good affinity of 1 and poor affinity of di-platinum
compound 2. Furthermore, we had reported that these com-
pounds are very selective binders to G4 DNA over duplex DNA
(up to 100-fold selectivity [55]).
Thus, given the good binding affinity and selectivity of the di-
copper compound to G4s, its G4-stabilising ability was further
investigated by the CD melting experiment (by measuring the
changes of G4 melting temperature, DTm) in the presence of
the ligand. In 10 mM compound 3, the CD spectrum of
MNSG4 dramatically changed from parallel to hybrid of
parallel/anti-parallel. The melting temperatures measured at
263 nm and 295 nm are 90.460.7uC and 86.262.1uC,
respectively (Figure S8 a and b). It is likely that the di-copper
compound preferentially binds to parallel MNSG4 structures
(possibly due to the exposed end G-tetrads in parallel
conformations), and thus promotes the transition of MNSG4
from anti-parallel to parallel structures. For the 280 G4, the
presence of the compound did not change its CD spectrum.
Due to the strong stabilising ability of the compound, only a
small fraction of the parallel 280 G4 was melted at 93uC, and
the melting temperature is estimated to be over 100uC (Figure
S8 c and d). The binding preference to parallel G4s observed
here might be due to the long loops in both MNSG4 and 280
G4. Long lateral or diagonal loops may partially or fully cover
the end G-tetrad, and impede the P–P stacking, while the long
external loops could leave enough space for the p–p stacking at
the end G-tetrad for the first metal moiety, and even provide
ideal electrostatic interactions sites for the second metal moiety.
Ligand Screening in Cell Model
Since these ligands were able to bind to the MNSG4 and 280
G4 in solution with relatively high affinity and selectivity, we aim
to investigate possible biological functions of these G4-binding
ligands and their interactions with these G4 elements in living
Figure 5. TnIc G4s unfolding curves and corresponding fitted curves. (a) Decrease of Cy5 fluorescence in the process of MNSG4 (formed
between oligos TrMNS-III and Comp-Cy5) opened by its C-rich complimentary strand (oligo TrMNS-II) at different temperature. Black, green, blue
and cyan curves are from experimental data obtained at 25, 35, 45, and 55uC, respectively, and red curves are fitted results by a double exponential
decay model. (b) Decrease of Cy5 fluorescence in the process of 280 G4 (formed between oligos Tr-80-III and Comp-Cy5) opened by its C-rich
complimentary strand (oligo Tr-80-II) at different temperature. Black, green, blue and cyan curves are from experimental data obtained at 35, 45, 55,
and 65uC, respectively, and red curves are fitted results by a double exponential decay model. Hybridisation was performed between 100 nM G4
forming oligos and 2 mM complimentary C-rich oligo. The reaction was carried out in 100 mM KCl solution containing 10 mM Tris-HCl (pH 7.4).
doi:10.1371/journal.pone.0053137.g005
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cells. Since both MNSG4 and 280 G4 are only conserved in TnIc
promoters in the primate genomes, HEK293 cell line, rather than
rat/mouse cardiomyocytes, was used. Dose-response curves of
compound 1–3 were generated by measuring the firefly (vector
hTnIc-6MNS(E)-WT) and Renilla luciferase ratios of lysates of
transfected HEK293 cells incubated in the presence of ligands at
different concentrations. Vector hTnIc-6MNS(E)-WT was used
because it contains the greater number of G4 repeats, which was
predicted to give the most significant response if the ligand-
stabilisation of G4s is involved in determining the promoter
activity. As shown in Figure 6 a, the mono-platinum compound 1,
showed a weak activating effect towards downstream gene
transcription with the promoter activity being increased 2-fold at
100 mM concentration (EC50 = 812 mM). The di-platinum com-
pound 2 exhibited modest activating effects towards downstream
luciferase transcription with the promoter activity being increased
by more than 3 times at 100 mM concentration (EC50 = 8.6 mM)
(Figure 6 b). By replacing platinum with copper, the third
compound (compound 3) demonstrated most significant activation
effect, which elevated the promoter activity by approximately 5-
fold at 100 mM concentration (EC50 = 0.6 mM) (Figure 6 c). These
results are in good agreement with the FID results that compound
3 is the best G4-binder among the three. Together, these
observations suggest that the di-copper compound 3 has the best
performance in living cells.
G4-binding Ligand is Critical in Promoting Positive
Regulatory Functions of TnIc Promoter G4s
To investigate the regulatory function of TnIc promoter G4s,
firefly and Renilla luciferase ratios of different vectors were
measured following incubation with and without the G4-binding
ligand compound 3. We found that compared to the engineered
wild type construct containing six repeats of consensus MNSG4,
human TnIc constructs containing three, one repeat, or no repeat,
exhibited similar activities in driving downstream luciferase
transcription (P$0.05, Figure 7 a and Figure S9). This indicates
Figure 6. Structures and dose-response curves of compound 1, 2, and 3. (a) Compound 1 only slightly activated downstream luciferase
expression (EC50 = 812.1 mM). (b) Compounds 2moderately activated downstream luciferase expression (EC50 = 1.6 mM). (c) Compound 3 significantly
activated downstream gene expression (EC50 = 0.6 mM). Experiments were carried out by measuring the firefly (hTnIc-6MNS(E)-WT) and Renilla
luciferase ratio changes in the presence of ligand with different concentrations.
doi:10.1371/journal.pone.0053137.g006
Table 5. MSN1DC50 and
280 G4DC50 values (mM) determined
using FID assay for complexes 1–3 (values are average of
three independent measurements and error is estimated to
be below 5%).
Compound MSN1DC50
280 G4DC50
1 0.76 0.55
2 0.39 2.22
3 0.31 0.19
doi:10.1371/journal.pone.0053137.t005
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Figure 7. Transcription activity changes of human TnIc promoters in the presence of compound 3. (a) Transcription activity of
constructed human TnIc promoters in the absence of compound 3. (b) Transcription activity of constructed human TnIc promoters in the presence of
100 mM compound 3. Columns in a and b are normalised to the luciferase transcription level of the wild type control 6MNS(E)-WT in the absence of
ligand. (c) Dose-response curves of compound 3 with different luciferase vectors. (**P,0.01, *P,0.05 and ¡P$0.05, no significant differences
compared to WT construct).
doi:10.1371/journal.pone.0053137.g007
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that in the absence of G4-binding ligands, neither the MNSG4 nor
Sp1 binding sites in the MNSG4 element appear to be involved in
regulating downstream gene transcription, at least in HEK293
cells.
Regulatory roles of the 280 G4 together with a conserved Sp1
binding site in the promoter of human TnIc were also investigated
by dual luciferase reporter assays in the HEK293 cell line in the
absence of G4-binding ligand. As shown in Figure 7 a and Figure
S10, the human TnIc construct containing 280 G4 with disrupted
G4-forming sequence but intact Sp1 binding site (hTnIc-80 G4-M)
has similar transcription activity to the engineered wild type
promoter (hTnIc-6MNS(E)-WT). However, when the Sp1 binding
site is mutated (hTnIc-80Sp1-M), transcriptional activity decreases
by,25%. Furthermore, when both the 280 G4-forming sequence
and Sp1 binding site are mutated (hTnIc-80 G4/Sp1-M, Figure
S10), transcriptional activity further decreases to 50% compared to
the engineered wild type promoter. This may relate to the further
mutated Sp1 binding site in vector hTnIc-80 G4/Sp1-M as
compared to that in vectors hTnIc-80Sp1-M, rather than the
disruption of the 280 G4 formation. Although the 280 G4 is not
directly involved in regulating downstream gene transcription, the
Sp1 binding site seems to be critical in determining downstream
gene expression. This is similar to the situation where an Sp1
binding site found in the G4-forming sequence (KIT1) in the
promoter of human KIT gene appears to be critical in determining
the maximal activity of the human KIT promoter [70].
The 280 G4 mutation (with an intact Sp1 binding site, hTnIc-
80 G4-M) which disrupts G4 formation, slightly elevated the
transcriptional activity of TnIc promoter. The overall G4 mutant,
hTnIc-6MNS/280 G4-M, exhibited lowest transcriptional activ-
ity (Figure 7 a). The decreased luciferase expression from this
vector may result from a combination of multiple mutation sites in
MNSG4 and 280 G4, which have disrupted the critical Sp1
binding site within the 280 G4, and may have introduced certain
inhibitory factor binding sites.
We conclude that in the absence of G4-binding ligand, both the
MNSG4 and 280 G4 are not involved in regulating downstream
gene transcription in HEK293 cells, and the depressed transcrip-
tion levels mainly relate to the disruption of the critical Sp1
binding site within 280 G4. As TnIc is exclusively expressed in
cardiomyocytes, we suspect that the formation and stabilisation of
these promoter G4s may be associated with certain cardiac-
specific proteins or TFs, which are absent in HEK293 cells. Since
it has been reported that short proximal promoter of human TnIc
is sufficient to confer cardiac-specific expression [71], it is possible
that the luciferase expression level of these vectors without ligands
is just the basal expression level in HEK293 cells. To test this
hypothesis, luciferase assays were repeated in the presence of
100 mM compound 3. As shown in Figure 7 b, when incubated
with compound 3 for 24 hours before cell lysis, the expression
activities of luciferase from all vectors increase differently.
Generally, the transcription activity of human TnIc promoter
gradually decreases when the number of MNSG4 repeat
decreases, while the lowest transcription activities were observed
in vectors with mutated 280 G4. It’s worth noting that in the
presence of ligand, the overall mutant, hTnIc-6MNS/280 G4-M,
was also activated for about 4 times as compared to the wild type
construct hTnIc-6MNS(E)-WT in the absence of ligand. This may
relate to the interaction between the ligand and a G-rich region in
the TnIc promoter (between 2260 and 2150 bp), which may
adopt multiple two-tetrad G4s.
To further discriminate activation effects of MNSG4 and 280
G4, dose-response curves of different luciferase vectors treated
with compound 3 were generated. As shown in Figure 7 c, the
strongest activation effect was observed in the vector with wild type
MNSG4 and280 G4 (hTnIc-6MNS(E)-WT), in which downstream
luciferase expression increases 6.5 times in the presence of 3.2 mM
compound 3. When the 280 G4 is intact, the activation effects of
downstream luciferase decreases proportionally with the decrease of
repeat number of MNSG4 (hTnIc-6MNS(E)-WT.hTnIc-
3MNS(E)-WT.hTnIc-1MNS(E)-WT.hTnIc-299-WT). However,
when the280 G4 is mutated (hTnIc-80 G4-M, hTnIc-6MNS/280
G4-M), lowest activation effects were observed again. These results
suggest that the 280 G4, which is located in a region with high
location significance (according to our hypothesis in bioinformatics
studies), may operate as a gatekeeper in regulating downstream
luciferase expression in HEK293 cells; the MNSG4, on the other
hand, acts as to a fine tune regulation when the280 G4 is intact. It is
likely that both types of G4s orchestrate the gene expression of
cardiac troponin I in the heart.
Discussion
The correlations between G4s and gene functions, and the
regulatory roles of promoter G4s in proto-oncogenes have been
thoroughly investigated previously, which has led to the applica-
tion of several G4-binding ligands as potential anticancer drugs (as
reviewed in [38,72]). There is now compelling evidence to support
the existence of G4 in vivo, such as G4-induced guanine-protection
revealed by in vivo DMS footprinting [23] (reviewed in [73]).
However, although it is clear that G4 complexes function in living
cells and there has been some good successes in designing specific
G4 binding small molecule ligands (reviewed in [38]), discrimi-
nating and targeting specific G4s via small synthetic G4-binding
ligands remains very challenging. Such efforts are hampered by
many factors including: (i) structural polymorphism and dynamic
properties of G4s, (ii) similar major recognition sites (G-tetrad) in
different G4s, (iii) limited precise structural data of G4s available,
(iv) low abundance and instability of G4s in the human genome as
compared to duplex DNA, (v) obstacles in synthesis of natural G4-
binding ligands and (vi) poor pharmaceutical properties of some
synthetic compounds. Among all these issues, the selectivity of G4-
binding ligands is the most notable one that warrants further
improvement. Although there are some ligands reported to
interact with G4s much more selectively than with duplex DNA,
such as MnIII porphyrin (104-fold) [74], and dimetallic terpyridine-
based ligand (over 100-fold) [55], the selectivity of most ligands are
in the range between 10- and 100-fold (reviewed in [38,39]).
Furthermore, very few ligands have been reported to exert
satisfactory selectivity between different G4s. Thus, we reason that
G4-binding ligands with ideal selectivity and affinity to a particular
promoter G4 structure would be difficult to achieve at the
moment, and off-target effects would be inevitable, limiting the
therapeutic potential of these ligands in vivo. However, off-target
effects or multi-targeting effects of G4-binding ligands may in turn
become advantageous and enhance their therapeutic potential in
some cases as mentioned in the Introduction section. This implies
that targeting multiple similar G4s in a particular pathway might
be feasible, and furthermore, this could be an alternative to
overcome selectivity problem of G4 ligands. Therefore, G4-
pathway correlation is particularly important in applying G4s as
potential targets for the treatment of certain diseases.
In this study, we first investigated the abundance of G4s in the
TRRs of genes active in different tissues. The tissue-specific and
location-specific enrichment of G4s in TRRs of genes were clearly
shown, particularly for the genes active in the heart. Enrichment of
G4s in different regions around TSS is known to associate with
diverse biological processes. For example, G4s in the distal or
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proximal promoters of proto-oncogenes normally act as repressors
in regulating downstream gene transcription (MYC promoter G4
[10,11]). G4s in the downstream regions relative to TSS can
modulate mRNA translation efficiency differently depending on
the strand polarity [35,36]. Thus, this tissue-specific, location-
specific, and asymmetric G4 enrichment may also imply that
tissues with high G4 abundance in TRRs or certain regions of
TRRs have evolved certain tissue-specific mechanisms to tolerate
or even to utilize G4s in the processes of transcription regulation.
Previous genome-wide studies have found that promoter G4s
have a strong positional bias towards TSS in different species
[6,35,59,61,75,76]. This positional bias of promoter G4 is believed
to be a result from evolution selection [6,37]. Thus, in addition to
G4 abundance (F score, and CF), the location significance of G4 (Q
score, and CQ) is also considered when evaluating the biological
importance of G4s in each TRR. Generally, correlation between F
and Q scores in G4-less-important TRRs is not as strong as that in
G4-important TRRs. Furthermore, we notice that when G4
importance increases, the probability of finding G4s in the
proximal (2500 bp,21 bp) promoter regions of TRR increases.
Because the majority of promoter G4s with proven regulatory
functions locate in the proximal promoter regions, it is highly likely
that the accumulation of proximal promoter G4s in pathways with
high G4 importance is biologically relevant. In regions down-
stream the TSS, however, the probability is relatively constant,
suggesting that the transcription induced G4 formation might be
ubiquitous in different genes.
G4-important pathways show significant connection with their
functions (Table 4). Particularly, in accordance to previous
findings, most cancer-related pathways are also G4-important,
which may suggest that off-target effects of certain anticancer G4-
binding ligands can provide extra benefits for cancer treatment.
Heart function-related pathways, especially those involved in
various cardiomyopathies, are also found to be highly G4-
important, indicating the therapeutic potential of G4s in
cardiovascular diseases.
Because of its high G4 importance and unique expression
pattern, the proximal promoter of human TnIc was chosen as a
model to investigate possible regulatory functions of G4s in cardiac
function-related genes. Two G4 elements, the MNSG4 and 280
G4 were analysed separately. Results from CD, EMSA and DMS
footprinting experiments have confirmed formation of these G4
elements in solution. Different folding patterns between these
cardiac promoter G4s and proto-oncogene promoter G4s may
relate to their distinct biological functions and therefore warrant
further investigation by NMR spectroscopy.
The stability of MNSG4 and 280 G4 were both evaluated by
their unfolding processes either thermodynamically and kinetical-
ly. Both have similar thermal stability (Table 6) as compared to the
human telomeric G4 [77,78], and other G4s with similar loop
length, such as MYC, KIT, WNT1 and VEGF G4s [4]. Kinetic
stability studies (Table S3) revealed that the unfolding of MNSG4
is entropically driven and that it can unfold relatively easily
[79,80]. On the other hand, the unfolding of the 280 G4s is
enthalpy-driven. According to limited kinetic stability data of other
G4s, the MNSG4 and the fast unfolding 280 G4 are slightly less
kinetically stable than the others, while the slow unfolding280 G4
is much more stable than the others (Oxytricha telomeric G4 [81],
KIT1 G4 [68], KIT2 G4 [68], and human telomeric G4 [60]). As
the biological roles of human telomeric,MYC, VEGF, and KIT G4s
have already been established, it is reasonable to assume that both
TnIc MNSG4 and 280 G4 are stable enough to possess certain
biological roles in the promoter of human TnIc in the context of
adjacent duplex.
Dose response curves from different constructs demonstrated
that the stabilisation of 280 G4 is critical in activating
downstream luciferase expression, while the individual MNSG4
acts as a fine-tuner. Since in HEK293 cells, most cardiac specific
proteins and transcription factors are absent, this activation effect
may be due to the negative twist from the formation of G4s in the
promoter region, which can facilitate the unwinding of supercoiled
plasmid DNA. The regulatory roles of G4 elements in human TnIc
promoter were mainly measured by comparing the transcription
activities of engineered human TnIc promoter in HEK293 cells
with and without the G4-binding ligand by dual luciferase reporter
assays. This is based on the assumption that the G4-binding
ligand, compound 3, is able to directly interact with these TnIc G4
elements in living cells, and subsequently to induce transcription
activity changes. However, similar to most studies published so far,
direct evidence indicating the interaction between G4-binding
ligands and G4s in living cells is extremely difficult to obtain and
could not be obtained in this study. However, several pieces of
indirect evidence support the conclusion that the positive
regulatory roles of these TnIc promoter G4s relate to the
stabilisation of these elements by the ligand. The first evidence is
the selectivity of the ligand to the TnIc G4 elements as compared
to the dsDNA. Previous studies showed that compound 3 exhibits
a relatively high selectivity to G4s as compared to dsDNA (, 100-
fold [55]), although its selectivity among different G4s is relatively
low. These features of compound 3 eliminate the doubts that this
ligand may interact with dsDNA, and change the transcription
activity of TnIc promoter in HEK293 cells indirectly (such as the
inhibitory effects of Quarfloxin towardsMYC [82,83]). The second
evidence is the preference of the ligand between the TnIc MNSG4
and 280 G4. Biophysical studies of G4-ligand interactions
indicated that the Cu-Cu compound has better performance
when interacting with the 280 G4. Similarly, in cell studies,
activation effects from the ligand-stabilised 280 G4 are more
prominent. Finally, the prevalent activating effect from 280 G4 in
regulating downstream gene expression is in good agreement with
our hypothesis in the bioinformatics studies about location
significance of promoter G4s (G4s found in the region with high
distribution probability are more important). Thus, although
additional experiments may be necessary to fully clarify the
interaction between compound 3 and TnIc G4 elements in the
context of a living cell, it is very likely that the activation effects of
these G4 elements are directly induced by interacting with the G4-
binding ligand.
In contrast to the widely observed G4-mediated phenomena in
promoters of oncogenes that formation and stabilisation of these
promoter G4s could impede downstream gene transcription, we
found that the formation and stabilisation of the MNSG4 and280
G4 could activate downstream gene transcription. This is similar
to the G4s found in the ILPR [8] and skeletal muscle gene
promoters [84]. The formation and functions of G4s around gene
promoters are dependent on local environment (transcription-
induced supercoiling, existence of transcription bubbles, etc.), and
the availability of G4-interacting proteins in a particular cell type.
Thus, we believe that the actual function of individual promoter
G4 needs to be studied case by case. Here we suggest two possible
mechanisms for this G4-mediated transactivation.
The first mechanism is related to the superhelicity of the testing
plasmid. It has been known that the formation of G4 structures
within the DNase I or S1 nuclease hypersensitive pPu/pPy tracts
in gene promoters are often associated with negative supercoiling
stress, which facilitates the local unwinding or melting of duplex
DNA [21,85,86], such as in cases of ILPR [87–89], VEGF [23,24]
and MYC [90]. Furthermore, the RNA polymerase (RNApol) can
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generate negative supercoiling during transcription [91]. It is
worth noting that this transcription-induced supercoiling force was
found to enable DNA transitions to conformations other than B-
DNA in an in vivo study of the MYC promoter [92]. Therefore, it
is possible that in the case of human TnIc promoter, the
stabilisation of multiple G4s by the ligand facilitates the local
unwinding of the negatively supercoiled plasmid, and resolves the
transcription-induced supercoiling forces, hence increasing tran-
scription rate. Since the 280 G4-forming motif locates very close
to the TSS, the formation of this G4 may exert stronger forces to
release the transcription-induced supercoiling stresses, as com-
pared to the MNSG4. In addition, the formation of the 280 G4
may result in the exposure of multiple TF binding sites around it
and facilitate the initiation of the transcription. This may explain
the ‘‘gatekeeper’’ role of the 280 G4 and ‘‘fine-tuner’’ role of the
MNSG4. We are aware that in vitro and in vivo DMS footprinting
[23,24] to probe the formation of these G4 elements would be
necessary to fully characterise this mechanism.
The G4/E-box-mediated mechanism is another possibility.
Recently, Shklover et al. proposed that the promoter G4s formed
in muscle-specific genes may function as binding sites for
homodimeric MyoD and increase its concentration in the micro-
environment around the promoters [84]. This accumulated
homodimeric MyoD then associate with constitutive E-proteins
to form heterodimers, which bind to adjacent E-box (E47) and
activate downstream gene expression [84]. Interestingly, in the
promoter of human TnIc, potential E-boxes are also identified
around both MNSG4 and 280 G4 [49]. In HEK293 cells, these
co-localized G4-forming motifs and adjacent E-boxes may provide
binding sites for constitutively expressed bHLH factors and E-
proteins, and hence transactivate the downstream luciferase gene.
This mechanism may also exist in the human cardiomyocyte, since
several cardiac-restricted bHLH proteins have been found to be
important in heart development, such as HAND1 and HAND2
[93–95].
In summary, this study shows that potential G4-forming motifs
are highly enriched in genes active in the heart as well as those
involved in cardiac function-related pathways. As shown in the
model of TnIc promoter, it is very likely that multiple G4s act
cooperatively in regulating downstream gene transcription. Thus,
multi-targeting strategy via promoter G4s could be utilised in
manipulating certain gene expression or even modulating pathway
performance. On the other hand, it is necessary that all the G4
forming motifs in a given promoter are carefully investigated to
understand their potential regulatory functions. It should be noted
that HEK293 cell line used in this study is a limited cell model, but
we have shown that it is still valuable to understand the ligand-
induced promoter activity changes of human TnIc. Cardiomyo-
cytes could be used in future studies to fully resolve the G4-
mediated regulatory mechanism.
Supporting Information
Figure S1 Distribution of G4 abundance scores (the F
scores) and corresponding cumulative frequencies (the
CF scores) on coding strand (a), template strand (b), and
both strands (c). In the analysis, TRRs from 46,205 transcripts
exported from ENSEMBL with redundancy were included. TRRs
of transcripts without G4-forming motifs were excluded in
calculating the distribution and corresponding cumulative fre-
quency.
(DOC)
Figure S2 Probability distribution and location signifi-
cance scores (the Q scores) distribution of G4s in TRRs
of transcripts. (a) Frequency of PQS (potential quadruplex
sequence) at each position (Wk as described in Equation 3) on
coding strand (black), template strand (red), and both strands
(green) in TRRs of all transcripts. TRRs from 46,205 transcripts
exported from ENSEMBL with redundancy were included. (b,d)
Distribution of G4 location significance (lower graphs) and
corresponding cumulative frequency (upper graphs) of all
transcripts available in ENSEMBL database on the coding
strands, template strand, and both strands, respectively. TRRs of
transcripts without G4-forming motifs were excluded in calculat-
ing the distribution and corresponding cumulative frequency.
(DOC)
Figure S3 Correlation between the location significance
(the CQ score) and abundance (the CF socre) of G4s
identified in TRRs of all transcripts with redundancy.
(a,c) Correlation between G4 location significance and G4
abundance on the coding strand (CQcd vs. CFcd), template strand
(CQncd vs. CFncd), and both strands (CQo vs. CFo), respectively. In
each map, transcripts with the TRRs CQ and CF scores larger than
50% are identified as G4-important transcripts, and those with
both values smaller than 50% are G4-less-important (or less G4-
important) transcripts. Correlation coefficients between CF and
CQ on coding strand (CFcd vs. CQcd), template strand (CFncd vs.
CQncd), and both strands (CFo vs. CQo) are 0.57, 0.50, and 0.61,
respectively. However, corresponding correlation coefficients for
G4-important TRRs are 0.61 (coding strand), 0.58 (template
strand), and 0.66 (both strands), respectively, while those for G4-
less important TRRs are 0.10, 0.09, and 0.34 respectively.
Apparently, in G4-important TRRs, their G4 abundance is more
positively correlated to their G4 location significance.
(DOC)
Figure S4 Native and denaturing gel electrophoresis
indicating the formation of G4s. (a) TnIc MNSG4, 1 repeat:
Lane1 and 2 are oligos TrMNS-II (C-rich) and TrMNS-I (G-rich)
run in a native gel. Lane 3 and 4 are oligos run in a denaturing gel
as controls. (b) TnIc 280 G4: Lane1 and 2 are oligos Tr-80-II (C-
rich) and Tr-80-I (G-rich) run in a native gel. Lane 3 and 4 are
Table 6. Energetics of TnIc MNSG4 and 280 G4 unfolding in solutions determined by CD melting.
Oligo Names Wavelength/nm Tm/6C DH/kJ mol21 DS/J mol21 K21 DG (310 K)/kJ mol21
TrMNS-I (TnIc MNSG4) 263 N/A N/A N/A N/A
295 71.460.5 170611 494631 17.261.3
Tr-80-I (TnIc 280 G4) 263 75.261.0 187622 538662 20.561.7
295 N/A N/A N/A N/A
Experiments were carried out in solutions containing 10 mM Tris-HCl (pH 7.4) and 100 mM K+.
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oligos run in a denaturing gel as controls. Formation of
intramolecular G4s is proved by species with fast mobility under
native conditions (indicated by black arrows) but not under
denaturing conditions. Intermolecular G4s formed by the 280 G4
forming sequence are indicated by gray arrows in (b).
(DOC)
Figure S5 DMS footprinting results of TnIc MNSG4 and
280 G4. (a) DMS footprinting of MNSG4 (oligo TrMNS-I).
Strong DMS protection is observed at G1,G3, G5,G7,
G11,G13, and G14,G15. Two guanines at the 39 of MNSG4
(G17,18, oligo TrMNS-I) are not involved in G4 formation.
Compared to other guanines involved in loops (G4, G8, and G9),
G10 is partially protected from DMS. Because G13 is fully
protected from DMS, this partial protection of G10 may be due to
the gyration hindrance from the adjacent G4 structure, which
blocks its access by DMS. (b) DMS footprinting of 280 G4 (oligo
TrMNS-I). In the first 59 run of guanines (G1,G5), partial
protection of guanines is apparent. Meanwhile, in the second and
third runs of guanines (G9,G12 and G13,G16), partially
protected flanking guanines in each G-run are also found (G9/
G12 and G12/G16) with two fully protected guanines in the
middle (G10,G11 and G14,G15). This poorly defined foot-
printing pattern of280 G4 element is possibly due to the long first
loop (at least 7 nucleotides) which induces flexibility of the G4
conformations. Together with CD experiments, it’s highly likely
that this sequence can fold into a mixture of exchanging parallel
intramolecular G4s with different loop arrangements in KCl
solution. Furthermore, in the second and third G-runs, it is clear
that G12 and G13 are better protected from DMS than G9 and
G16, which may reflect the preference of different intramolecular
G4s.
(DOC)
Figure S6 CD melting of the two promoter G-quad-
ruplex sequences. (a) single-repeat MNSG4. (b) 280 G4.
(DOC)
Figure S7 Arrhenius plot for unfolding of TnIc G4s. (a)
Arrhenius plot for the slow decaying component identified in the
unfolding process of TnIc MNSG4. Empty circles represent
opening rates measured at different temperatures, and red line is
the result fitted by Arrhenius equation. The activation energy is
determined to be 22.160.4 kJ mol21. (b) Arrhenius plot for the
slow and fast decaying components identified in the unfolding
process of TnIc 280 G4. Empty triangles and squares represent
opening rates of the fast and slow decaying components,
respectively, and red lines are results fitted by Arrhenius equation.
The activation energies for the fast and slow decaying components
are 86.1623.7 and 100.666.6 kJ mol21, respectively, as deter-
mined by the fits.
(DOC)
Figure S8 CDmelting of TnIc MNSG4 and280 G4 in the
presence of the G4-binding ligand (complex 3). (a) CD
melting spectra of TnIc MNSG4 (oligo TrMNS-I, 5 mM) in the
presence of 10 mM complex 3. (b) CD signal changes of TnIc
MNSG4 (oligo TrMNS-I) at 295 nm (black dots) and 263 (red
dots) nm wavelengths in response to temperature changes, both of
which were fitted by a sigmoidal model (indicated by red line and
black line respectively). The melting temperature measured at
265 nm and 295 nm are 90.460.7uC and 86.262.1uC respec-
tively (c) CD melting spectra of TnIc 280 G4 (oligo Tr-80-I,
5 mM) in the presence of 10 mM complex 3. (d) CD signal changes
of TnIc 280 G4 (oligo Tr-80-I) at 295 nm (black dots) and 263
(red dots) nm wavelengths in response to temperature changes,
both of which were fitted by a sigmoidal model (indicated by red
line and black line respectively). All experiments were carried out
in 10 mM Tris-HCl buffer (pH 7.4) containing 100 mM K+.
(DOC)
Figure S9 Comparison of the transcription activities of
human TnIc promoters containing variable number of
MNSG4. Transcription activities of human TnIc promoters
containing 6 repeats of consensus MNSG4 (hTnIc-6MNS(E)-
WT), 3 repeats of consensus MNSG4 (hTnIc-3MNS(E)-WT), 1
repeat of consensus MNSG4 (hTnIc-1MNS(E)-WT), and no
repeat of MNSG4 (hTnIc-299-WT). No transcription activity
difference was found among these human TnIc promoters
(P$0.05, no significant differences).
(DOC)
Figure S10 Transcription activities of human TnIc
promoters with wild type and mutated 280 G4. Mutation
of 280 G4 alone (hTnIc-80 G4M) did not change the
transcription activity, while the mutation of Sp1 binding site
(hTnIc-80sp1M-1/2) led to,25% depression in the transcription
activity. When both G4 formation and Sp1 binding sites were
mutated (hTnIc-80 G4/sp1M), 50% decrease of the transcription
activity was found (* P,0.05 and ¡ P$0.05 no significant
differences).
(DOC)
Table S1 The rankings and scores of G4 enrichment in
TRRs of genes active in different tissues. G4s in the full-
length TRR (Whole TRR), distal promoter region
(22,000,2501 bp), proximal promoter region (2500,21 bp),
and downstream region (TSS,+1,000 bp) were searched and the
procedure was repeated randomly for five times.
(DOC)
Table S2 CFo and CQo values of TRRs of genes
containing well-studied promoter G4s.
(DOC)
Table S3 Parameters obtained from curve fittings of
TnIc MNSG4 and 280 G4 unfolding in solution.
(DOC)
Protocols S1 Supporting protocols including G4-binding
ligand synthesis, Electrophoretic mobility shift assay,
CD characterization, DMS footprinting, unfolding ki-
netics and the human genome sequence data bases used
in the bioinformatic analysis.
(DOC)
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